Caja de Compensación Familiar CAFAM
About Caja de Compensación Familiar CAFAM
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
2
Clinical Trials at Caja de Compensación Familiar CAFAM
During the past decade, Caja de Compensación Familiar CAFAM conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF
2018-06-15
2019-11-04
Completed
789
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%
2020-09-14
2024-09-13
Active, not recruiting
6,016
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Caja de Compensación Familiar CAFAM"
#1 collaborator was "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Caja de Compensación Familiar CAFAM
According to Clinical.Site data, the most researched conditions in "Caja de Compensación Familiar CAFAM" are
"Chronic Heart Failure With Preserved Ejection Fraction" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Caja de Compensación Familiar CAFAM" in a lesser frequency.
Clinical Trials Intervention Types at Caja de Compensación Familiar CAFAM
Most popular intervention types in "Caja de Compensación Familiar CAFAM" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Finerenone (BAY94-8862)" (1 trials) and "Vericiguat (BAY1021189) 2.5 mg, 5 mg or 10 mg IR tablets" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Caja de Compensación Familiar CAFAM
The vast majority of trials in "Caja de Compensación Familiar CAFAM" are
2 trials for "All" genders.
Clinical Trials Status at Caja de Compensación Familiar CAFAM
Currently, there are NaN active trials in "Caja de Compensación Familiar CAFAM".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Caja de Compensación Familiar CAFAM,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Caja de Compensación Familiar CAFAM, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".